Xponance’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $852K | Sell |
30,897
-14,515
| -32% | -$400K | 0.01% | 751 |
|
|
2025
Q1 | $1.29M | Buy |
45,412
+642
| +1% | +$18.2K | 0.01% | 613 |
|
|
2024
Q4 | $1.86M | Sell |
44,770
-414
| -0.9% | -$17.2K | 0.02% | 544 |
|
|
2024
Q3 | $3.02M | Buy |
45,184
+1,112
| +3% | +$74.3K | 0.03% | 426 |
|
|
2024
Q2 | $5.23M | Sell |
44,072
-387
| -0.9% | -$46K | 0.05% | 272 |
|
|
2024
Q1 | $4.74M | Buy |
44,459
+2,050
| +5% | +$218K | 0.05% | 311 |
|
|
2023
Q4 | $4.22M | Buy |
42,409
+2,489
| +6% | +$248K | 0.05% | 303 |
|
|
2023
Q3 | $4.12M | Buy |
39,920
+910
| +2% | +$94K | 0.06% | 283 |
|
|
2023
Q2 | $4.74M | Sell |
39,010
-3,629
| -9% | -$441K | 0.06% | 262 |
|
|
2023
Q1 | $6.55M | Sell |
42,639
-2,753
| -6% | -$423K | 0.1% | 192 |
|
|
2022
Q4 | $8.15M | Buy |
45,392
+5,479
| +14% | +$984K | 0.13% | 148 |
|
|
2022
Q3 | $4.72M | Buy |
39,913
+9,307
| +30% | +$1.1M | 0.09% | 199 |
|
|
2022
Q2 | $4.37M | Sell |
30,606
-27,604
| -47% | -$3.94M | 0.09% | 192 |
|
|
2022
Q1 | $10M | Sell |
58,210
-2,998
| -5% | -$516K | 0.17% | 103 |
|
|
2021
Q4 | $15.5M | Buy |
61,208
+4,984
| +9% | +$1.27M | 0.24% | 73 |
|
|
2021
Q3 | $21.6M | Buy |
56,224
+16,646
| +42% | +$6.41M | 0.41% | 38 |
|
|
2021
Q2 | $9.3M | Buy |
39,578
+9,543
| +32% | +$2.24M | 0.17% | 104 |
|
|
2021
Q1 | $3.93M | Buy |
30,035
+441
| +1% | +$57.7K | 0.08% | 199 |
|
|
2020
Q4 | $3.09M | Sell |
29,594
-155
| -0.5% | -$16.2K | 0.07% | 238 |
|
|
2020
Q3 | $2.11M | Buy |
29,749
+1,797
| +6% | +$127K | 0.05% | 278 |
|
|
2020
Q2 | $1.8M | Buy |
+27,952
| New | +$1.8M | 0.05% | 282 |
|